- Illustrations
- Specialized Illustrations
- Disease-specific
- Sagittal Section Of The Uterus Showing A Sarcoma
Sagittal Section Of The Uterus Showing A Sarcoma
Sarcoma within a sagittal section of the uterus, appearing as a mass within the myometrial wall.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Uterine sagittal anatomy is opened in the midline to expose the endometrial cavity and surrounding myometrium, with the fundus superior and the cervix inferior. A sarcomatous mass expands the myometrial wall, bulging toward the endometrial cavity while also approaching the serosal surface, so the lesion reads as intramural rather than purely submucosal. Anterior and posterior uterine walls remain identifiable around the mass, and the uterine cavity provides a stable landmark for judging depth of myometrial involvement. Margins look irregular. Uterine sarcoma matters because its clinical behavior and management differ sharply from common leiomyoma, even when both present as a myometrial mass on ultrasound or MRI. In a fixed sagittal section, you can immediately judge whether the tumor distorts the endometrium (a correlate for abnormal uterine bleeding) and how close it lies to the serosa and cervix, details that influence staging and the surgical plan for total hysterectomy with or without salpingo-oophorectomy. The cut-surface emphasis on myometrial infiltration also supports teaching the difference between a pushing, well-circumscribed fibroid and an infiltrative malignant process such as leiomyosarcoma or endometrial stromal sarcoma. Use this illustration in gynecologic oncology lectures when discussing FIGO staging, patterns of local invasion, and why morcellation is avoided when sarcoma is a concern. It also fits pathology teaching sets on uterine smooth muscle tumors and board-style questions contrasting degenerating leiomyoma versus sarcoma in a sagittal uterine section. Anatomical accuracy verified by SciePro's Medical Advisory Board.